CHRISTINE HORNE: Open Payments
NPI 1942755368 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,173 in 15 payments from 6 companies in 2025. Trend: 2023 $4,669 · 2024 $9,373 · 2025 $2,173
Consulting: $1,110Food & beverage: $1,063
| Company | Payments | Amount |
|---|---|---|
| PTC Therapeutics, Inc. | 6 | $882 |
| Cycle Pharmaceuticals Inc | 1 | $560 |
| BioMarin Pharmaceutical Inc. | 4 | $298 |
| Chiesi USA, Inc. | 1 | $159 |
| GENZYME CORPORATION | 2 | $156 |
| Ultragenyx Pharmaceutical Inc. | 1 | $118 |
Products named: Javygtor, SEPHIENCE, ELFABRIO, Palynziq, Dojolvi, NEXVIAZYME, VOXZOGO 1.2mg.
Industry payments across IL — which companies pay providers there.
